ÂÜÀòÂÒÂ×

Johnny Zou began their career in 2011 as a Research Assistant at Mizuho. Johnny then worked as a Research Analyst at J.P. Morgan from 2012 to 2013. From 2013 to 2020, they were an Executive Director at Primavera Capital Group. In 2020, they became a Board Director at ZAP Surgical Systems, Inc., a Board Member at Accutar Biotech, and a Board Observer at Xbiome. Johnny currently serves as a Board Member at Accession Therapeutics Limited.

Johnny Zou attended SFLS from 1999 to 2006. Johnny then went on to receive a Bachelor of Arts (B.A.) in Theirtory from Yale University from 2006 to 2010. Afterward, they attended The London School of Economics and Political Science (LSE) from 2010 to 2011, where they obtained an MSc in Economic Theirtory.